What does CUSIP 53630X104 represent in this 13F holders report?

CUSIP 53630X104 is the security identifier for LPCN - LIPOCINE INC NEW - COM used to aggregate holder disclosures.

How many institutions held LPCN - LIPOCINE INC NEW - COM in Q2 2017?

41 institutional investors reported LPCN - LIPOCINE INC NEW - COM for Q2 2017. Use the holders table for investor-level position and value details.

LIPOCINE INC NEW - COM (LPCN)

CUSIP: 53630X104

Q2 2017 13F Holders as of 30 Jun 2017

Security type / class: Equity / COM
Total 13F shares: 5,454,487
Total 13F value: $21,925,016
Share change: -1,944,270
Put/Call ratio: 71%
SEC-reported price per share: $4.02
Number of holders: 41
Value change: -$7,631,787
Number of buys: 23
Number of sells: 28

Security key

53630X104

Report period

Q2 2017

Institutions

Top holders

LPCN full security history Ownership snapshot Full 13F holder table Lipocine Inc. SEC filings Lipocine Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of LPCN - LIPOCINE INC NEW - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ROYCE & ASSOCIATES LP

Disclosed value leader

ROYCE & ASSOCIATES LP

Comparable rows

0/15

Latest evidence

31 Mar 2017

13F Highest disclosed value: $4,597,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

ROYCE & ASSOCIATES LP has the largest disclosed position value at $4.6M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ROYCE & ASSOCIATES LP's linked filing trail.

Disclosed position value Top 5

ROYCE & ASSOCIATES LP $4.6M

Invesco Ltd. $4.15M

BlackRock Finance, Inc. $3.8M

Cormorant Asset Management, LP $2.89M

Carlson Capital, L.P. $2.64M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ROYCE & ASSOCIATES LP	13F Company 13F	— denominator unverified	$4,597,000 1,178,704 shares	—	31 Mar 2017
Invesco Ltd.	13F Company 13F	— denominator unverified	$4,153,000 1,064,739 shares	—	31 Mar 2017
BlackRock Finance, Inc.	13F Company 13F	— denominator unverified	$3,802,000 974,693 shares	—	31 Mar 2017
Cormorant Asset Management, LP	13F Company 13F	— denominator unverified	$2,892,000 741,496 shares	—	31 Mar 2017
Carlson Capital, L.P.	13F Company 13F	— denominator unverified	$2,639,000 676,574 shares	—	31 Mar 2017
VHCP Management II, LLC	13F Company 13F	— denominator unverified	$1,638,000 420,000 shares	—	31 Mar 2017

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2017

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

5,454,487

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2017 vs Q1 2017 Across Filers

Q1 2017 holders

Q2 2017 holders

Holder diff

-6

Investor	Q1 2017 Shares	Q2 2017 Shares	Share Diff	Share Chg %	Q1 2017 value	Q2 2017 value	Value change	Value Chg %